-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Hebei Guangxiang Technology Co., Ltd.
(Drug Research Institute of SSY Group Limited)
The Drug Research Institute of SSY Group Limited was found in 2013, it is the Technology Center of enterprise, the National-Local Joint Engineering Laboratory and the Innovation Achievement Transformation Center, integrating pharmaceutical research, drug registration, clinical research, patent affairs and information management.
The company is dedicated to providing comprehensive and professional research and consulting services for excellent enterprises at home and abroad. Its main business covers pharmaceutical research, drug registration, clinical research, clinical trials, medical market, clinical trial quotation, project evaluation, patent affairs, information management and industrialization, and so on.
The company has a high-level professional research team of synthesis, analysis, preparations and APIs with more than 80% of the staff with doctoral and master degrees, and a series of advanced, high-precision and cutting-edge detection and monitoring equipment such as high performance liquid chromatograph, ultra-high performance liquid chromatograph, atomic absorption spectrophotometer, liquid chromatography-mass spectrometry and gas chromatograph as well as the pilot laboratory and pilot production line in accordance with the GMP requirements.
The company is in the national advanced level of aspects such as infusion quality, production technology and safety control technology research. It has a post-doctoral research station approved by the Ministry of Human Resources and Social Security, a National and Local Joint Engineering Laboratory for Quality Control of Chemical Injections approved by the National Development and Reform Commission, and an Enterprise Technology Center recognized by Five Ministries and Commissions including the National Development and Reform Commission. The company has completed the projects of National Science and Technology Support Program launched by the Ministry of Science and Technology, such as "Preclinical safety evaluation of new pharmaceutical excipients and safety study of compatibility between drugs and medical packaging materials". It has obtained a number of scientific research achievements and undertaken a number of major provincial science and technology innovation and industrialization projects, and won the first prize of Science and Technology Progress of Hebei Province for many times.
In recent years, based on the collaborative innovation mechanisms with many well-known universities and research institutes, we have established provincial academician cooperation units with Academician Wang Guangji, and jointly established innovation centers with universities and research institutes including Tsinghua University, China Pharmaceutical University, Shenyang Pharmaceutical University, Zhejiang University, Zhengzhou University and Tianjin University to promote breakthroughs in the research of small molecule compounds and specialty first generic drugs, and to boost the enterprise’s R&D and innovation to a medium-high end of the industrial and value chain.
Honors Qualification
SERVICE HOTLINE
Mobile site
E code
